Product correctly added to cart.

Cinepazide
View 3D

Biosynth logo

Cinepazide

CAS: 23887-46-9

Ref. 3D-FC148892

5mgDiscontinued
10mgDiscontinued
25mgDiscontinued
50mgDiscontinued
100mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
Cinepazide
Synonyms:
  • 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazine
  • 1-[4-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
  • 1-{4-[2-Oxo-2-(Pyrrolidin-1-Yl)Ethyl]Piperazin-1-Yl}-3-(3,4,5-Trimethoxyphenyl)Prop-2-En-1-One
  • 2-Propen-1-one, 1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-
  • 23887-46-9
  • Piperazine, 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-
  • Piperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-
Description:

Cinepazide is a drug that is used to treat diabetes mellitus. It is a basic protein that has been shown to have statistically significant effects on neuronal death, mitochondrial membrane potential, and enzyme activities in the mitochondria of rats. Cinepazide also has been shown to have mitochondrial functions. This drug decreases the risk of cardiovascular events in patients with coronary heart diseases and improves energy metabolism by decreasing glucose levels in the blood. Cinepazide may cause side-effects such as headache, dizziness, and nausea.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
417.5 g/mol
Formula:
C22H31N3O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-FC148892 Cinepazide

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".